Gordon Naylor work email
- Valid
- Valid
- Valid
- Valid
Gordon Naylor personal email
Gordon Naylor phone numbers
Experienced business and people leader in challenging international environments at Board, CEO and Executive levelsDeep skills in business strategyStrong skills in global supply chain and information systems strategy and implementationExperienced corporate manager, especially acquisitions and post-acquisition integration;Strong business governance skills and senseExperienced in facilitating large cross-functional international teams;Experienced expatriate;Driver of rapid and sustainable organisational change;Very strong analytical skills;Well adapted to learning new skills as required andSolid professional background
-
Ceo And Managing DirectorCslIvanhoe, Vic, Au
-
Chair - ElectCsl SeqirusIvanhoe, Vic, Au
-
Non Executive DirectorCelleo Biotech Aug 2024 - PresentMelbourne, Victoria, Australia -
Non Executive DirectorOrica Mar 2022 - PresentMelbourne, Victoria, AustraliaChair of the Board Audit and Risk CommitteeMember of the Safety and Sustainability Committee -
Non Executive ChairmanMedical Developments International Dec 2020 - PresentMelbourne, Victoria, AustraliaAppointment of a turnaround Chief Executive OfficerSuccessful $36m capital raisingRapidly renewing the Board to bring needed skills for support of the CEO and a completelyrebuilt leadership teamStrongly supporting the CEO through the turnaround processCommenced a significant strengthening of governance and accountability systems -
DirectorMedical Developments International Oct 2020 - PresentMelbourne, Victoria, Australia
-
PresidentSeqirus Aug 2015 - Jun 2019Maidenhead (United Kingdom)Led the business combination of Novartis Influenza Vaccines and bioCSL through a dramatic turnaround. Over three years, revenue and profit both improved by over US$300m bringing the business to sustainable profitabilitySimultaneously built a complete set of organisational infrastructure, including a leadershipteam, integrated organisation, multiple offices including headquarters and a complete IT system(including a full SAP implementation).Established a powerful culture built on openness and competence.Seqirus today is recognised as the global industry leader in influenza and a key public healthpartnerLaunched multiple products in multiple jurisdictionsBrought to reality the novel cell culture manufacturing method – the first major change ininfluenza manufacturing since the 1940s. The method was demonstrated to offer significantimprovements in vaccine effectiveness.
-
Chief Financial OfficerCsl Jun 2010 - Dec 2015Parkville, Victoria, AustraliaLed the CSL finance team and supported the CEO through a period of significant capital appreciationDeveloped and implemented a capital management strategy that drive significant shareholder value by prudently increasing balance sheet efficiencyTransitioned CSL’s reporting currency from AUD to USDExtended CSL’s investor relations reachSupported a successful CEO transitionResponsibilities included corporate CSL strategy, M&A and the turnaround of the BioCSLbusinessManaged the purchase of Novartis Influenza Vaccines (NIV) at a substantial discount tocarrying value
-
Executive Vice President; Plasma, Supply Chain And Information SystemsCsl Behring Dec 2007 - Jun 2010Philadelphia, Pennsylvania, United StatesRetained executive responsibility for CSL Plasma and successfully transitioned the businessleadership. CSL Plasma continues to show extraordinary performance, innovation and growth;Assumed responsibility for CSL Behring’s global planning and logistics functions. Drovedevelopment of both functions to better integrate the business, increase supply chain visibilityand facilitate CSL Behring business performance through a period of strong growth as weworked through capacity constraints and managed global inventory levels; Assumed responsibility for CSL’s global Information Systems in December 2008 (CIO forCSL). Rapidly established a clear strategic agenda and put in place organisational mechanismsto fully globalise the function andElected chairman of the PPTA Source Board in October 2007 and have helped to guide theglobal plasma collection industry through a series of important regulatory issues and to shapethe industry body’s strategic direction
-
Non Executive DirectorWhitelion Feb 2015 - Dec 2015West Melbourne, Victoria, AustraliaWorked to support the charitable work of White Lion until moving overseas. Introduced improved financial analysis/reporting and supported a strategic review of the operation -
General Manager And Senior Vice PresidentZlb Plasma Services May 2002 - Jun 2007Boca Raton, Florida, United StatesLeadership of a CSL business unit, headquartered in the US with a turnover of ca US$700m, staff of ca 4,000 and operations across the US and Germany;Responsible for the management of ca 30% of the world’s traded human blood plasma;Led ZLB Plasma from a small, inefficient player to strong industry leadership in terms of scale, innovation and efficiency with profound strategic implications for the CSL groupSuccessfully managed the integration of two plasma collection operations following the acquisition of Aventis Behring by CSL. Rationalised around 40 operations within weeks of deal closure resulting in release of significant cash needed to fund the acquisition;Made significant operational productivity improvements in a tough commodity business over several years andManaged business through a serious industry downturn requiring significant production reductions and capacity rationalisation and more recently a period of aggressive growth needed to support CSL Behring’s expansion. -
Head, Business ProjectsZlb Bioplasma Ag Sep 2001 - May 2002Bern, Berne, SwitzerlandBroad corporate development role, supporting the development of a corporate group structure within ZLB;Heavily involved in all merger and acquisition activity for the ZLB group;Responsible for the ZLB group strategic planning process andResponsible for the deal closure and then integration of ZLB Plasma (acquired in September 2001 for ca A$300m). This project involved development of significant corporate infrastructure and business improvements.
-
Director Of IntegrationZlb Bioplasma Sep 2000 - Aug 2001Bern, Berne, SwitzerlandResponsible for the integration of ZLB (based in Switzerland) into the CSL group. The acquisition (worth ca A$1b) presented significant cultural challenges and had far-reaching consequences for the CSL group andManaged a strategic review of a number of key CSL group functions, triggered by the rapid globalisation of the business. -
Special Projects Director (Bioplasma Division)Csl Jan 1998 - Sep 2000Vienna, AustriaResponsible for international facilities projects for the division as part of a major strategic move to export process and engineering technology;Project Director responsible for CSL's contribution to a green-fields plasma products facility in Poland (project value ca US$100m). Responsible for establishing and managing a trans-global team, working in Australia, Austria, Ireland and Poland andEstablished project offices in Austria and Ireland and lived as an expatriate in both countries, before moving to Switzerland.
-
Engineering And Logistics Manager (Bioplasma Division)Csl Jul 1996 - Dec 1997Broadmeadows, Victoria, AustraliaResponsibilities increased to include the Materials Management function (purchasing, stores, distribution and plasma intake). ;Whilst on study leave managed a major divisional strategy review that laid the foundations for CSL’s international growth.
-
Engineering Manager (Bioplasma Division)Csl Sep 1992 - Jun 1996Broadmeadows, Victoria, AustraliaFirst Chief Engineer at the new facility. Responsibility for 200 staff, annual expenditure of around A$14M and capital expenditure of around A$14M;Oversaw the transition of a large team from a project environment into operational structures and systems, with a strong focus upon efficient, stable operations;Achieved ISO9001 certification for the engineering group ;Achieved real cost savings of 12% pa over 4 years, whilst simultaneously significantly improving all measured service and performance levels;Actively involved in numerous improvement and management initiatives, including risk management, IT strategy, implementation of MRP II to achieve certified Class A standard of operations and continuous improvement;
-
Senior Project EngineerCsl Jun 1987 - Aug 1992Melbourne, Victoria, AustraliaPlayed a key role as part of a large project team responsible for building a human blood Plasma Products Facility for Australia. This facility was highly innovative and was the foundation asset for CSL's commercial success;Responsible for electrical, communication, computer and automation systems. Primary responsibility was the sophisticated automation system for the facility.Lead a team of around 200, made up of project, operational and contract staff;Spent 6 months in 1991, working in Europe on behalf of CSL, managing all European projectcontracts
-
Plant EngineerFord Motor Company Feb 1985 - Jun 1987Geelong, Victoria, AustraliaRecruited to Ford's Graduate Training Programme;Exposed to most aspects of high volume manufacturing and project engineering andBuilt manufacturing infrastructure for the introduction of the EA Falcon.
Gordon Naylor Skills
Gordon Naylor Education Details
-
Cpa Australia ProgramCpa -
Master Of Business Administration - Mba -
Computer Science -
Honours
Frequently Asked Questions about Gordon Naylor
What company does Gordon Naylor work for?
Gordon Naylor works for Csl
What is Gordon Naylor's role at the current company?
Gordon Naylor's current role is CEO and Managing Director.
What is Gordon Naylor's email address?
Gordon Naylor's email address is go****@****.com.au
What is Gordon Naylor's direct phone number?
Gordon Naylor's direct phone number is +161033*****
What schools did Gordon Naylor attend?
Gordon Naylor attended Cpa Australia Program, Melbourne Business School, University Of Melbourne, University Of Melbourne.
What skills is Gordon Naylor known for?
Gordon Naylor has skills like Pharmaceutical Industry, Biotechnology, Change Management, Strategy, Business Strategy, Strategic Planning, Clinical Development, Management, Drug Development.
Who are Gordon Naylor's colleagues?
Gordon Naylor's colleagues are Victoria Lyons, Jane Sadler, Alexander Maharam, Stephan Henzen, Mary Cecovski, Debra Demalignon, Ricky Sawi.
Not the Gordon Naylor you were looking for?
-
2gmail.com, nancycampbell.net2 +151980XXXXX
-
1pepstores.com -
2icbc.com, worksafebc.com -
2gmail.com, nancycampbell.net1 +151980XXXXX
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial